U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020-February 2022.

ABSTRACT: SARS-CoV-2 seroprevalence surveys provide critical information to assess the burden of COVID-19, describe population immunity, and guide public health strategies. Early in the pandemic, most of these surveys were conducted within high-income countries, leaving significant knowledge gaps in low-and middle-income (LMI) countries. To address this gap, the U.S. Centers for Disease Control and Prevention (CDC) is supporting serosurveys internationally. We conducted a descriptive analysis of international serosurveys supported by CDC during May 12, 2020-February 28, 2022, using an internal tracker including data on the type of assistance provided, study design, population surveyed, laboratory testing performed, and status of implementation. Since the beginning of the pandemic, CDC has sup

SUBMITTER: Hamida AB 

PROVIDER: S-EPMC9490761 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature